Literature DB >> 12197884

Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells.

H Bartz1, F Büning-Pfaue, O Türkel, U Schauer.   

Abstract

Bronchiolitis caused by respiratory syncytial virus (RSV) infection is a major cause of hospitalization in children under 1 years of age. The disease characteristically does not induce protective immunity. However, a mononuclear peribronchiolar and perivascular infiltrate during RSV infection is suggestive of an immune-mediated pathogenesis. Macrophages and dendritic cells (DCs) play an essential role in the initiation and maintenance of immune response to pathogens. To analyse interactions of RSV and immune cells, human cord blood derived macrophages and dendritic cells were infected with RSV. Both cells were found to be infected with RSV resulting in the activation of macrophages and maturation of dendritic cells as reflected by enhanced expression of several surface antigens. In the next set of experiments, generation of mediators was compared between cells infected with RSV, parainfluenza (PIV3) and influenza virus as well as ultracentrifuged virus free supernatant. Whereas the supernatant did not induce release of mediators, all three live virus infections induced IL-6 production from macrophages and DC. Influenza virus infection induced predominantly IL-12 p75 generation in DC. In contrast, RSV induced strong IL-11 and prostaglandin E2 release from both macrophages and DCs. In addition, RSV but not influenza and parainfluenza virus induced a strong IL-10 generation particularly from macrophages. Since IL-10, IL-11 and PGE2 are known to act immunosuppressive rather than proinflammatory, these mediators might be responsible for the delayed protective RSV specific immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12197884      PMCID: PMC1906469          DOI: 10.1046/j.1365-2249.2002.01927.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

Review 1.  Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm.

Authors:  P G Holt; P A Stumbles
Journal:  J Allergy Clin Immunol       Date:  2000-03       Impact factor: 10.793

2.  IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils.

Authors:  E Minshall; J Chakir; M Laviolette; S Molet; Z Zhu; R Olivenstein; J A Elias; Q Hamid
Journal:  J Allergy Clin Immunol       Date:  2000-02       Impact factor: 10.793

3.  Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

Authors:  N Sigurs; R Bjarnason; F Sigurbergsson; B Kjellman
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

4.  Differential effects of respiratory syncytial virus and adenovirus on mononuclear cell cytokine responses.

Authors:  P V Díaz; W J Calhoun; K L Hinton; L F Avendaño; A Gaggero; V Simon; S M Arredondo; R Pinto; A Díaz
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

5.  Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection.

Authors:  A Marx; H E Gary; B J Marston; D D Erdman; R F Breiman; T J Török; J F Plouffe; T M File; L J Anderson
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

6.  Increased number of T cells committed to IL-5 production after respiratory syncytial virus (RSV) infection of human mononuclear cells in vitro.

Authors:  A M Thurau; H J Streckert; C H Rieger; U Schauer
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

7.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

8.  IL-6 induces long-term protective immunity against a lethal challenge of influenza virus.

Authors:  S W Lee; J W Youn; B L Seong; Y C Sung
Journal:  Vaccine       Date:  1999-02-05       Impact factor: 3.641

Review 9.  Respiratory syncytial virus infection.

Authors:  E A Simoes
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

10.  Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.

Authors:  P Kaliński; J H Schuitemaker; C M Hilkens; M L Kapsenberg
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

View more
  42 in total

1.  Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant.

Authors:  Caitlin M Briggs; Robert C Holder; Sean D Reid; Griffith D Parks
Journal:  Microbes Infect       Date:  2010-12-24       Impact factor: 2.700

2.  Characterization of human metapneumovirus infection of myeloid dendritic cells.

Authors:  Maria C Tan; Lorenzo Battini; Ana C Tuyama; Salvador Macip; Guillermina A Melendi; Maria-Arantxa Horga; G Luca Gusella
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

Review 3.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Protective effect of resveratrol against pseudorabies virus-induced reproductive failure in a mouse model.

Authors:  Dingding Su; Shusong Wu; Jing Guo; Xiaosong Wu; Qing Yang; Xingyao Xiong
Journal:  Food Sci Biotechnol       Date:  2016-03-31       Impact factor: 2.391

5.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus.

Authors:  Cyril Le Nouën; Philippa Hillyer; Eric Levenson; Craig Martens; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 7.  IDO-expressing regulatory dendritic cells in cancer and chronic infection.

Authors:  Alexey Popov; Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

8.  Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.

Authors:  Pablo A González; Carolina E Prado; Eduardo D Leiva; Leandro J Carreño; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

9.  Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Authors:  Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

10.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.